ACCELERATE DIAGNOSTICS INC - NOTE 2.500% 3/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q2 2023

Type / Class
Debt / NOTE 2.500% 3/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ACCELERATE DIAGNOSTICS INC - NOTE 2.500% 3/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2023 Q2 $0 $0 -$2,773,125 0
2023 Q1 $3,000,000 $2,773,125 -$33,477,837 92.44% 1
2022 Q4 $41,414,000 $38,650,837 -$234,881 93.48% 8
2022 Q3 $41,414,000 $38,779,000 -$24,357,000 91.51% 8
2022 Q2 $78,409,000 $52,350,000 -$16,386,839 68.0% 9
2022 Q1 $101,429,000 $70,060,000 -$7,276,515 67.62% 12
2021 Q4 $112,179,000 $83,390,000 +$4,226,757 74.73% 12
2021 Q3 $107,400,000 $76,129,000 +$783,970 70.32% 13
2021 Q2 $124,016,000 $82,860,000 +$196,000 66.1% 13
2021 Q1 $117,145,000 $80,100,000 -$6,914,000 67.28% 11
2020 Q4 $129,180,000 $76,406,000 +$66,022 57.88% 13
2020 Q3 $126,270,000 $82,581,000 -$297,178 63.88% 11
2020 Q2 $115,710,000 $82,711,000 -$382,605 71.23% 11
2020 Q1 $126,300,000 $71,855,000 -$7,992,937 54.91% 14
2019 Q4 $125,300,000 $97,465,000 -$1,711,942 77.24% 14
2019 Q3 $127,550,000 $104,376,000 -$2,366,608 81.52% 14
2019 Q2 $130,750,000 $114,421,000 +$114,421,000 84.61% 14